← Leaderboards
Carol O Cowing
Lancell, Llc
$2,625,076
Attributed
$2,625,076
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $673.6K · FY2007–11$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$2,625,076 · 3
By mechanism
R44$2,037,838 · 2
R43$587,238 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesPublic Health Medicine (Field)Dendritic CellsMorbidity - Disease RatePandemic InfluenzaProductionFluzoneImmunityInjection Of Therapeutic AgentMedicalPandemic DiseaseCostAntigensPre-ClinicalInfluenza Virus VaccineAntiviral AgentsDoseAntibody FormationEconomicsAdjuvantLifeLymph NodesAntibodiesMortality Vital Statistics
Grant awards (6)
Topical adjuvants to enhance the efficacy of influenza vaccines$614,206
R44 · FY2011 · AI · contact PI
Topical adjuvants to enhance the efficacy of influenza vaccines$673,631
R44 · FY2010 · AI · contact PI
Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines$293,619
R43 · FY2008 · AI · contact PI
Topical Adjuvants to Enhance the Efficacy of Influenza Vaccines$293,619
R43 · FY2007 · AI · contact PI
TRANSPORT OF PEPTIDES TO EPIDERMAL LANDGERHANS CELLS$375,001
R44 · FY2003 · CA
TRANSPORT OF PEPTIDES TO EPIDERMAL LANDGERHANS CELLS$375,000
R44 · FY2002 · CA